Metabolomic biomarkers for the diagnosis and post-transplant outcomes of AFP negative hepatocellular carcinoma

BACKGROUND: Early diagnosis for α-fetoprotein (AFP) negative hepatocellular carcinoma (HCC) remains a critical problem. Metabolomics is prevalently involved in the identification of novel biomarkers. This study aims to identify new and effective markers for AFP negative HCC. METHODS: In total, 147 p...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Zuyuan, Li, Huigang, He, Chiyu, Yang, Modan, Chen, Hao, Yang, Xinyu, Zhuo, Jianyong, Shen, Wei, Hu, Zhihang, Pan, Linhui, Wei, Xuyong, Lu, Di, Zheng, Shusen, Xu, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947281/
https://www.ncbi.nlm.nih.gov/pubmed/36845695
http://dx.doi.org/10.3389/fonc.2023.1072775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947281/
https://www.ncbi.nlm.nih.gov/pubmed/36845695
http://dx.doi.org/10.3389/fonc.2023.1072775

Ejemplares similares